Regeneration of periodontal tissues by basic fibroblast growth factor.
Several growth factors (or cytokines) have recently received attention because of their ability to actively regulate various cellular functions of periodontal ligament (PDL) cells and the effects of topical application of such factor(s) on periodontal tissue regeneration has been evaluated. In this study, we examined the role of basic fibroblast growth factor (bFGF) in the wound healing and regeneration of periodontal tissues. Alveolar bone defects (such as 2-wall, 3-wall and furcation class II bone defects) were created surgically in beagle dogs and primates. Recombinant bFGF was topically applied to the artificial bony defects. Six or 8 wk after application, the periodontal regeneration was morphologically and histomorphometrically analyzed. In all sites where bFGF was applied, significant periodontal ligament formation with new cementum deposits and new bone formation was observed in amounts greater than in the control sites. We found it noteworthy that no instances of epithelial down growth, ankylosis or root resorption were observed in the bFGF sites. In vitro studies demonstrated that bFGF enhances the proliferative responses of human PDL cells, which express FGF receptor-1 and -2, but inhibits the induction of alkaline phosphatase activity and mineralized nodule formation by PDL cells. Interestingly, we observed that the mRNA level of laminin in PDL cells, which plays an important role in angiogenesis, was specifically upregulated by bFGF stimulation, but that of type I collagen was downregulated. The present study demonstrates that bFGF can be applied as one of the therapeutic modalities which actively induce periodontal tissue regeneration. The results of in vitro studies suggest that by suppressing the cytodifferentiation of PDL cells into mineralized tissue forming cells, bFGF may play important roles in wound healing by promoting angiogenesis and inducing the growth of immature PDL cells, and may in turn accelerate periodontal regeneration.
Murakami
S
S
Department of Periodontology and Endodontology, Osaka University Faculty of Dentistry, Japan. ipshinya@dent.osaka-u.ac.jp
Takayama
S
S
Ikezawa
K
K
Shimabukuro
Y
Y
Kitamura
M
M
Nozaki
T
T
Terashima
A
A
Asano
T
T
Okada
H
H
D000287:Administration, Topical; D000469:Alkaline Phosphatase / Q000037:antagonists & inhibitors; D016301:Alveolar Bone Loss / Q000188:drug therapy / Q000473:pathology; D000818:Animals; D000844:Ankylosis / Q000517:prevention & control; D002455:Cell Division / Q000187:drug effects; D003094:Collagen / Q000187:drug effects; D003739:Dental Cementum / Q000187:drug effects; D004285:Dogs; D015536:Down-Regulation; D004848:Epithelium / Q000187:drug effects; D016222:Fibroblast Growth Factor 2 / Q000008:administration & dosage / Q000627:therapeutic use*; D017823:Furcation Defects / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D007797:Laminin / Q000187:drug effects; D008252:Macaca fascicularis; D008297:Male; D018919:Neovascularization, Physiologic / Q000187:drug effects; D010012:Osteogenesis / Q000187:drug effects; D010513:Periodontal Ligament / Q000187:drug effects / Q000473:pathology; D010519:Periodontium / Q000187:drug effects* / Q000473:pathology; D017468:Receptors, Fibroblast Growth Factor / Q000187:drug effects; D011994:Recombinant Proteins; D012038:Regeneration / Q000187:drug effects*; D012391:Root Resorption / Q000517:prevention & control; D015854:Up-Regulation; D014945:Wound Healing / Q000187:drug effects
D007797:Laminin; D017468:Receptors, Fibroblast Growth Factor; D011994:Recombinant Proteins; D016222:Fibroblast Growth Factor 2; D003094:Collagen; D000469:Alkaline Phosphatase